An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Researchers explored the long-term effects of preschool expansion in Japan in the 1960s, revealing significant reductions in risky behaviors amongst teenagers. By analyzing regional differences in the rollout of the program, the study identified links between early childhood education and lower rates of juvenile violent arrests and teenage pregnancy. The findings suggest that improved noncognitive […]

Although sedentary behavior may be an evolutionarily selected trait, it is still important to try to be physically active, says a new study. Researchers have shown for the first time that genetic predisposition to sedentary behavior is associated with a higher risk of developing the most common cardiovascular diseases. A high genetic predisposition to sedentary […]